Coronary Artery Calcium Score in HIV Mexican Population (The CACsHIVMex Study)

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstituto Mexicano del Seguro Social

About this trial

The risk of atherosclerotic cardiovascular disease is increased in people with HIV infection, including young patients and those with few traditional cardiovascular risk factors. The increased risk of cardiovascular disease among people living with HIV is due to accelerated atherosclerosis, caused by chronic inflammation and immune dysregulation. The measurement of coronary calcium using plain computed tomography is a subclinical indicator of coronary atherosclerosis and is associated with the risk of cardiovascular events and mortality in the general population.

Eligibility criteria

Qualifiers

Patients who have been diagnosed with HIV infection for more than 6 months

Undetectable viral load

Disqualifiers

Patients who have previously taken statins

Patients with chronic ischemic heart disease that has required stenting or revascularization

Trial design

Treatments tested in this trial

  • Simple coronary CT scan

Treatment groups

384 Participants
are divided into 1 treatment group